Prosecution Insights
Last updated: October 02, 2026

Examiner: HAN, SETH

Tech Center 3700 • Art Units: 1613 3781 3783

This examiner grants 60% of resolved cases

Analysis

Seth Han is an examiner in Art Unit 1613 within Tech Center 3700. The examiner has 182 resolved cases and an allowance rate of 59.3 percent. This baseline provides a clear view of the prosecution landscape for applications in this biotechnology or medical device technology area. The 59.3 percent rate suggests a balanced approach to examination, with a majority of the cases reaching a grant.

The median days to allowance for these cases is 1099. This timeline indicates that successful applications may face a moderate prosecution process. Practitioners should account for the 1099-day duration when advising clients on patent strategy and potential delays. The figure serves as a benchmark for pendency expectations for applications that ultimately reach an allowance in Art Unit 1613.

The data highlights an interview lift of 28.5 percent. This is a significant figure, suggesting that interviews are an effective mechanism for advancing prosecution and securing an allowance. The 28.5 percent lift indicates that a formal discussion with the examiner can improve the 59.3 percent baseline allowance rate. For practitioners, scheduling an interview appears to be a productive tactical decision to move a case toward a positive outcome.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

59.6%
Allow Rate
-10.4% vs TC avg
225
Total Applications
+28.8%
Interview Lift
1102
Avg Prosecution Days
Based on 183 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
15.1%
§102 Novelty
56.3%
§103 Obviousness
20.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18348992 HYBRID WATER RESERVOIR FOR AN ENDOSCOPE Non-Final OA Boston Scientific Scimed, Inc.
17962701 DRAINAGE DEVICE Non-Final OA Boston Scientific Scimed, Inc.
18437800 ABSORBENT ARTICLES INCLUDING IMPROVED ELASTIC PANELS Final Rejection The Procter & Gamble Company
18354304 Dynamic Leash for Dynamic Gastric Bypass Device Non-Final OA Mayo Foundation for Medical Education and Research
18223269 Occluder Devices for Dynamic Gastric Bypass Device Final Rejection Mayo Foundation for Medical Education and Research
18980185 DRESSING FOR NEGATIVE PRESSURE WOUND THERAPY WITH FILTER Non-Final OA Smith & Nephew PLC
18893837 NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES AND METHODS WITH INTEGRATED ELECTRONICS Non-Final OA Smith & Nephew PLC
17601020 DATA RECORDER IN WOUND THERAPY SYSTEMS Final Rejection T.J.Smith and Nephew,Limited
19306642 ELECTRONIC WIRELESS ORAL SUCTION DEVICE Non-Final OA Anew Oral Ltd
18569470 Urinary Catheter Container Final Rejection C. R. Bard, Inc.
18238432 NOZZLE FOR A FLUID DELIVERY DEVICE Non-Final OA Verily Life Sciences LLC
18063828 PLEURAL DRAINAGE CATHETER Final Rejection Cook Medical Technologies LLC
17624298 SUBSTRATE, ABSORBENT ARTICLE AND METHOD FOR WETNESS MONITORING Non-Final OA ONTEX GROUP NV
18074165 EXTRACORPOREAL LIFE SUPPORT SYSTEM Final Rejection LivaNova Deutschland GmbH
18690227 VENTRICULAR CATHETERS AND OTHER EMBODIMENTS Final Rejection Wayne State University
18882466 Methods and Systems for Collecting Whole Blood from a Donor and Maintaining Fluid Volume Non-Final OA Fenwal, Inc.
18839013 CORNEAL PATH ONE-WAY AQUEOUS HUMOR DRAINAGE DEVICE Non-Final OA BEIJING INSTITUTE OF OPHTHALMOLOGY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month